{ "company": "Danaher Corporation", "ticker": "DHR", "period": { "from": "2026-03-11", "to": "2026-04-10", "days": 30 }, "sentiment_breakdown": { "positive": 27, "negative": 19, "neutral": 32 }, "synthesis": { "executive_summary": "Sentiment analysis for Danaher Corporation (DHR) from 2026-03-11 to 2026-04-10. Analyzed 78 items across FDA and news sources.", "key_findings": [], "overall_sentiment": "neutral" }, "top_positive": [ { "title": "Danaher (DHR) Projects 2026 Revenue Growth at TD Cowen 46th Annual Health Care Conference", "date": "2026-03-24", "source": "news", "score": 0.9 }, { "title": "Danaher: After a Long Reset Period, Profit Growth Looks Likely to Accelerate in the Medium Term", "date": "2026-04-06", "source": "alpha_vantage", "score": 0.871 }, { "title": "[Latest] Global Environmental Mass Spectrometry Market Size/Share Worth USD 6.47 Billion by 2035 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)", "date": "2026-04-02", "source": "news", "score": 0.859 }, { "title": "Flow Cytometry Market Set to Surpass USD 12.19 Billion by 2035, Driven by Rising Demand for Precision Diagnostics – SNS Insider", "date": "2026-04-08", "source": "news", "score": 0.718 }, { "title": "Global Trust Asset Management LLC Grows Position in Danaher Corporation $DHR", "date": "2026-04-04", "source": "alpha_vantage", "score": 0.7 }, { "title": "Danaher’s Profit Report Challenge: Will First Quarter 2026 Address the Valuation Discrepancy Caused by Masimo?", "date": "2026-04-06", "source": "alpha_vantage", "score": 0.694 }, { "title": "Danaher Corporation $DHR Shares Acquired by Aaron Wealth Advisors LLC", "date": "2026-04-08", "source": "alpha_vantage", "score": 0.66 }, { "title": "Dental Fillers Market Report 2026-2032: Emerging Opportunities, Market Dynamics, Competitive Landscape Analysis", "date": "2026-03-18", "source": "news", "score": 0.66 }, { "title": "All New Liv Embolden Gets All the Right Updates for an Affordable Modern Trail", "date": "2026-04-08", "source": "news", "score": 0.625 }, { "title": "URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—MASI, AVO, CVGW, and TPH", "date": "2026-03-19", "source": "news", "score": 0.59 } ], "top_negative": [ { "title": "California State University board meeting falls into chaos amid SJSU lawsuit vs Trump admin over trans scandal", "date": "2026-03-12", "source": "news", "score": -1.0 }, { "title": "What May (or May Not) Get University Employees Fired", "date": "2026-04-03", "source": "news", "score": -0.896 }, { "title": "Biopsy Devices Market Size Projected to Reach USD 5.08 Billion by 2035; Increasing Incidence of Cancer to Drive Market Growth Globally – SNS Insider", "date": "2026-03-20", "source": "news", "score": -0.572 }, { "title": "Mondraker Leaves Something to the Imagination with Early Tease of Avinox-Powered ZENDIT eMTB", "date": "2026-03-27", "source": "news", "score": -0.557 }, { "title": "Longer duration of amenorrhea is associated with lower delay discounting and less hedonic eating in girls and young women with low-weight eating disorders.", "date": "2026 Apr 3", "source": "pubmed", "score": -0.542 }, { "title": "Purvalanol A (CDK Inhibitor) Market Report 2026: Expanding Molecular Biology and Cancer Research Fuelling Market Growth", "date": "2026-04-07", "source": "news", "score": -0.527 }, { "title": "Predictive Biomarkers Market to Reach USD 156.85 Billion by 2035; Rising Adoption of Precision Medicine and Targeted Therapies Driving Market Growth – SNS Insider", "date": "2026-03-17", "source": "news", "score": -0.477 }, { "title": "Wayne Tinkle Shows Class During Messy Ouster As Oregon State Disrespects Fired Basketball Coach", "date": "2026-03-16", "source": "news", "score": -0.468 }, { "title": "Danaher Corp. stock underperforms Wednesday when compared to competitors despite daily gains", "date": "2026-04-08", "source": "alpha_vantage", "score": -0.458 }, { "title": "Evaluating Danaher (DHR) After Mixed Recent Returns And Conflicting Undervaluation Signals", "date": "2026-04-07", "source": "alpha_vantage", "score": -0.402 } ], "raw_data": { "total_items": 78, "items": [ { "source": "alpha_vantage", "title": "Douglas Lane & Associates LLC Grows Position in Danaher Corporation $DHR", "url": "https://www.marketbeat.com/instant-alerts/filing-douglas-lane-associates-llc-grows-position-in-danaher-corporation-dhr-2026-04-10/", "date": "2026-04-10", "summary": "Douglas Lane & Associates LLC increased its stake in Danaher Corporation (NYSE:DHR) by 3.5% in the fourth quarter, bringing its total holdings to 437,475 shares valued at $100.15 million. The article also details other institutional investors increasing their positions, analyst ratings, and the company's recent financial performance, including a dividend increase. Danaher is a diversified global science and technology company operating in life sciences, diagnostics, and environmental and applied", "sentiment_score": 0.397943, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Partnership With PRECISE Puts Proteomics At Core Of TMO Story", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-tmo/thermo-fisher-scientific/news/thermo-fisher-partnership-with-precise-puts-proteomics-at-co", "date": "2026-04-10", "summary": "Thermo Fisher Scientific has partnered with Precision Health Research, Singapore (PRECISE) for a large-scale proteomics biobank initiative, the PRECISE-SG100K project. This collaboration will utilize Thermo Fisher's platforms, like Olink PEA and Orbitrap Astral mass spectrometry, within one of Asia's largest longitudinal population health studies. For investors, this signifies Thermo Fisher's deeper integration into global research infrastructure and its commitment to providing high-end tools fo", "sentiment_score": 0.283705, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.707414, "sentiment": { "label": "positive", "score": 0.2, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "Danaher Corp. stock underperforms Thursday when compared to competitors", "url": "https://www.marketwatch.com/data-news/danaher-corp-stock-underperforms-thursday-when-compared-to-competitors-7c9a035e-35c10acabf3d", "date": "2026-04-09", "summary": "Danaher Corp. (DHR) shares fell by 1.63% on Thursday, closing at $192.99, despite a positive trading session for the broader market where both the S&P 500 Index and Dow Jones Industrial Average saw gains. The stock is currently 20.51% below its 52-week high of $242.80, which it reached on January 22nd. The article highlights DHR's underperformance relative to its competitors and overall market trends for the day.", "sentiment_score": -0.273842, "sentiment_label": "Somewhat-Bearish", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.2, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "Masimo stock price target raised to $180 by Jefferies on Danaher deal", "url": "https://www.investing.com/news/analyst-ratings/masimo-stock-price-target-raised-to-180-by-jefferies-on-danaher-deal-93CH-4605988", "date": "2026-04-09", "summary": "Jefferies has increased its price target for Masimo (NASDAQ:MASI) to $180 from $168, maintaining a Hold rating, in anticipation of Danaher's acquisition of the company. The deal, valued at $9.9 billion or $180 per share, is expected to finalize in the second half of 2026. Despite the stock appearing slightly overvalued currently, the acquisition offers Danaher a relative discount compared to Masimo's existing market valuation.", "sentiment_score": 0.308686, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.914542, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "DNA Sequencing Market Leading Players Analysis - Abbott", "url": "https://www.openpr.com/news/4462560/dna-sequencing-market-leading-players-analysis-abbott", "date": "2026-04-09", "summary": "The global DNA Sequencing Market is experiencing significant growth, projected to register a 20% CAGR from 2025 to 2031, driven by technological advancements, expanding clinical applications, and increased investment in genomics research. Key players include Abbott Laboratories, Agilent Technologies, and Danaher Corporation, with North America dominating and Asia-Pacific emerging as a high-growth region. The market is fueled by applications in clinical diagnostics, agriculture, environmental sci", "sentiment_score": 0.325411, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.943972, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Hollow Fiber TFF Modules Market Is Going to Boom| Repligen", "url": "https://www.openpr.com/news/4462396/hollow-fiber-tff-modules-market-is-going-to-boom-repligen", "date": "2026-04-09", "summary": "Coherent Market Insights has published a report titled \"Hollow Fiber TFF Modules Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2026-2033,\" outlining market percentages and comprehensive enterprise analysis. The report details the market's competition, geographical distribution, and growth potential, making it a crucial resource for entrepreneurs, investors, researchers, consultants, and business strategists. It identifies key players such as Repligen Corporation, Merck ", "sentiment_score": 0.223853, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.829895, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Intuitive Surgical’s rivals eye soft tissue robotic surgery", "url": "http://www.modernhealthcare.com/medical-devices/mh-intuitive-surgical-soft-tissue-robotic-surgery/", "date": "2026-04-09", "summary": "Competitors are emerging to challenge Intuitive Surgical in the soft tissue robotic surgery market. The article, authored by Lauren Dubinsky, highlights this development in the medical devices sector. This indicates a potential increase in competition for Intuitive Surgical.", "sentiment_score": -0.144729, "sentiment_label": "Neutral", "relevance_score": 0.60888, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific stock: Steady growth amid biotech shifts – what investors need to know", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/thermo-fisher-scientific-stock-steady-growth-amid-biotech-shifts-what/69107374", "date": "2026-04-08", "summary": "Thermo Fisher Scientific is positioned for steady growth in the life sciences sector, driven by its integrated approach to drug development and research, and key product launches. The company's strong financial performance, consistent revenue growth, and strategic acquisitions allow it to maintain a competitive edge. Investors are advised to consider its long-term potential, while monitoring macroeconomic factors and upcoming earnings reports.", "sentiment_score": 0.135925, "sentiment_label": "Neutral", "relevance_score": 0.607509, "sentiment": { "label": "positive", "score": 0.382, "confidence": 0.38 } }, { "source": "alpha_vantage", "title": "Danaher Corp. stock underperforms Wednesday when compared to competitors despite daily gains", "url": "https://www.marketwatch.com/data-news/danaher-corp-stock-underperforms-wednesday-when-compared-to-competitors-despite-daily-gains-0b9d33c8-ec1cd0e0d3ce?mod=mw_quote_news", "date": "2026-04-08", "summary": "Danaher Corp. (DHR) stock rose 2.71% on Wednesday, closing at $196.19. Despite this daily gain, the stock underperformed when compared to the S&P 500 Index and the Dow Jones Industrial Average, which saw larger percentage increases. The company's stock also remains significantly below its 52-week high.", "sentiment_score": 0.005617, "sentiment_label": "Neutral", "relevance_score": 0.331102, "sentiment": { "label": "negative", "score": -0.458, "confidence": 0.46 } }, { "source": "alpha_vantage", "title": "Danaher Corp. Experiences Revision in Its Stock Evaluation Amid Competitive Market Landscape", "url": "https://www.marketsmojo.com/news/stocks-in-action/danaher-corporations-valuation-grade-changes-from-expensive-to-very-expensive-3938083", "date": "2026-04-08", "summary": "Danaher Corp., a Pharmaceuticals & Biotechnology firm, is undergoing a stock evaluation revision due to its high P/E ratio of 41 and P/B of 3.23. Despite a 5.75% return over the past year, its year-to-date performance shows a 16.56% decline, underperforming the S&P 500, especially when compared to peers like Abbott Laboratories and Thermo Fisher Scientific with more favorable valuation metrics.", "sentiment_score": 0.020885, "sentiment_label": "Neutral", "relevance_score": 0.345784, "sentiment": { "label": "positive", "score": 0.178, "confidence": 0.18 } }, { "source": "alpha_vantage", "title": "Sivik Global Healthcare LLC Trims Stock Holdings in Danaher Corporation $DHR", "url": "https://www.marketbeat.com/instant-alerts/filing-sivik-global-healthcare-llc-trims-stock-holdings-in-danaher-corporation-dhr-2026-04-08/", "date": "2026-04-08", "summary": "Sivik Global Healthcare LLC reduced its stake in Danaher Corporation by 34.3% in Q4, selling 12,000 shares but retaining 23,000 shares valued at $5.265 million. Danaher reported strong quarterly earnings, beating expectations, and increased its quarterly dividend. The company maintains a \"Moderate Buy\" consensus rating from analysts, with significant institutional ownership.", "sentiment_score": 0.104795, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "9,123 Shares in Danaher Corporation $DHR Purchased by Oak Thistle LLC", "url": "https://www.marketbeat.com/instant-alerts/filing-9123-shares-in-danaher-corporation-dhr-purchased-by-oak-thistle-llc-2026-04-08/", "date": "2026-04-08", "summary": "Oak Thistle LLC initiated a new position in Danaher Corporation (NYSE: DHR) during the fourth quarter, acquiring 9,123 shares valued at approximately $2.09 million. This purchase contributes to the roughly 79.05% institutional ownership of the company. Danaher recently increased its quarterly dividend to $0.40, and analysts generally maintain a \"Moderate Buy\" rating with an average target price of $253.79 after the company surpassed Q4 earnings and revenue estimates.", "sentiment_score": 0.521751, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "Wolfe Research Adjusts Price Target on Danaher to $230 From $260, Maintains Outperform Rating", "url": "https://www.marketscreener.com/news/wolfe-research-adjusts-price-target-on-danaher-to-230-from-260-maintains-outperform-rating-ce7e50dade8af421", "date": "2026-04-08", "summary": "Wolfe Research has adjusted its price target for Danaher (DHR) to $230, down from the previous $260, while maintaining an Outperform rating on the stock. This update comes alongside other analyst adjustments, with Jefferies setting a target of $240 and Evercore ISI at $225, all maintaining positive ratings. Danaher specializes in diagnostic, life sciences, and biotechnology equipment, with its next earnings release scheduled for Q1 2026 on April 21.", "sentiment_score": -0.231942, "sentiment_label": "Somewhat-Bearish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.2, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "Danaher Corporation $DHR Shares Acquired by Aaron Wealth Advisors LLC", "url": "https://www.marketbeat.com/instant-alerts/filing-danaher-corporation-dhr-shares-acquired-by-aaron-wealth-advisors-llc-2026-04-08/", "date": "2026-04-08", "summary": "Aaron Wealth Advisors LLC significantly increased its stake in Danaher Corporation (NYSE:DHR) by 331.7% in Q4, acquiring 5,891 additional shares to hold a total of 7,667 shares valued at $1.755 million. Danaher surpassed quarterly earnings and revenue estimates and analysts maintain a \"Moderate Buy\" rating with a consensus target price of $253.79. The company also recently boosted its quarterly dividend to $0.40 per share.", "sentiment_score": 0.449549, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.66, "confidence": 0.66 } }, { "source": "alpha_vantage", "title": "Evercore ISI Cuts Danaher (DHR) Price Target, Adds Shares to Tactical Outperform List", "url": "https://www.insidermonkey.com/blog/evercore-isi-cuts-danaher-dhr-price-target-adds-shares-to-tactical-outperform-list-1733828/", "date": "2026-04-08", "summary": "Evercore ISI analyst Vijay Kumar has lowered the price target for Danaher Corporation (DHR) to $225 from $254, while maintaining an Outperform rating and adding the shares to the firm's \"Tactical Outperform\" list. This comes after Danaher reported Q4 2025 sales of $6.8 billion and full-year sales of $24.6 billion, with adjusted operating profit margin of 28.2% and adjusted diluted EPS of $7.80. The company, which operates in Biotechnology, Life Sciences, and Diagnostics segments, also generated ", "sentiment_score": 0.051254, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.2, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "Envista (NYSE: NVST) outlines 2026 virtual meeting, proposals and 2025 results", "url": "https://www.stocktitan.net/sec-filings/NVST/def-14a-envista-holdings-corp-definitive-proxy-statement-a84869c5ace6.html", "date": "2026-04-07", "summary": "Envista Holdings Corporation (NYSE: NVST) has detailed its 2026 virtual annual meeting, scheduled for May 19, 2026, where stockholders will vote on electing eight directors, ratifying Ernst & Young LLP as the auditor, and casting an advisory vote on executive compensation and its frequency. The company reported strong financial results for 2025, with total revenue of $2,719.5 million and net income of $47.0 million, alongside significant improvements in Adjusted EBITDA and diluted EPS. Envista a", "sentiment_score": 0.100228, "sentiment_label": "Neutral", "relevance_score": 0.749857, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Capital Bancorp (CBNK) outlines director elections, say-on-pay and auditor vote", "url": "https://www.stocktitan.net/sec-filings/CBNK/def-14a-capital-bancorp-inc-definitive-proxy-statement-f27992fd4167.html", "date": "2026-04-07", "summary": "Capital Bancorp is set to hold its annual shareholder meeting on May 28, 2026, where stockholders will vote on key proposals including the election of five directors (four Class III and one Class II), an advisory \"say-on-pay\" vote for Named Executive Officers' compensation, and the ratification of Elliott Davis, PLLC as the independent auditor for 2026. The Board unanimously recommends voting \"FOR\" all proposals, citing a classified board structure for stability and significant insider ownership", "sentiment_score": 0.063919, "sentiment_label": "Neutral", "relevance_score": 0.547701, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Azenta names Trey Martin president of Multiomics business By Investing.com", "url": "https://uk.investing.com/news/company-news/azenta-names-trey-martin-president-of-multiomics-business-93CH-4596209", "date": "2026-04-07", "summary": "Azenta, Inc. has appointed Trey Martin as President of its Multiomics business, effective April 6, 2026. Martin, previously CEO of Maravai Life Sciences and holding senior roles at Danaher Corporation, brings over 30 years of experience in life sciences and genomics platforms. This leadership change follows a period of stock volatility for Azenta, despite recent positive developments like an acquisition and strategic partnerships.", "sentiment_score": 0.326265, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.647793, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "How Bio-Techne's Spatial Biology COMET Expansion (TECH) Has Changed Its Investment Story", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tech/bio-techne/news/how-bio-technes-spatial-biology-comet-expansion-tech-has-cha", "date": "2026-04-07", "summary": "Bio-Techne recently expanded its COMET spatial biology portfolio with new SPYRE Focus Panels, SPYRE Amplification Kits, and upgraded HORIZON image analysis software. This move aims to enhance automated, modular tissue analysis and deepen the company's high-content spatial biology offerings. While this expansion reinforces Bio-Techne's long-term investment narrative focused on specialized tools, near-term challenges such as funding pressures in biotech and academia remain, making execution on hig", "sentiment_score": 0.126834, "sentiment_label": "Neutral", "relevance_score": 0.607359, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "How Investors May Respond To Thermo Fisher Scientific (TMO) Expanding Its Cell Therapy And Biologics Platforms", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-tmo/thermo-fisher-scientific/news/como-podrian-reaccionar-los-inversores-ante-la-ampliacion-de-39", "date": "2026-04-07", "summary": "Thermo Fisher Scientific recently expanded its cell therapy and biologics platforms with new product launches and collaborations, including the CTS Compleo cell therapy system, CHOvantage biologics platform, Glacios 3 cryo-TEM, and a partnership with SHL Medical. These moves aim to strengthen Thermo Fisher's position in biomanufacturing and advanced research, potentially offsetting challenges in academic funding and analytical instruments. While analysts are optimistic about the revenue growth p", "sentiment_score": 0.158601, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.67, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Trading Systems Reacting to (DHR) Volatility", "url": "https://news.stocktradersdaily.com/news_release/90/Trading_Systems_Reacting_to_DHR_Volatility_040726014801_1775584081.html", "date": "2026-04-07", "summary": "This article from Stock Traders Daily discusses how their AI-powered trading systems are reacting to volatility in Danaher Corporation (NYSE: DHR). It provides key findings, sentiment analysis, and outlines three distinct trading strategies (Position, Momentum Breakout, and Risk Hedging) with specific entry, target, and stop-loss levels. The report also includes a multi-timeframe signal analysis, highlighting support and resistance levels for near, mid, and long-term horizons, and notes a prevai", "sentiment_score": 0.109013, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Evaluating Danaher (DHR) After Mixed Recent Returns And Conflicting Undervaluation Signals", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-dhr/danaher/news/evaluating-danaher-dhr-after-mixed-recent-returns-and-confli", "date": "2026-04-07", "summary": "Danaher (DHR) is currently facing mixed investor sentiment due to a year of positive returns contrasted with recent declines over the last three months and month, alongside a 4.5% uptick in the past week. Despite having a projected fair value of $264.91, suggesting it's 27.5% undervalued, other analyses indicate a 13.2% undervaluation but with an expensive P/E ratio. The article advises investors to further analyze the company's prospects given these conflicting signals and potential risks.", "sentiment_score": 0.139472, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.402, "confidence": 0.4 } }, { "source": "alpha_vantage", "title": "Fulton Breakefield Broenniman LLC Reduces Stock Holdings in Danaher Corporation $DHR", "url": "https://www.marketbeat.com/instant-alerts/filing-fulton-breakefield-broenniman-llc-reduces-stock-holdings-in-danaher-corporation-dhr-2026-04-07/", "date": "2026-04-07", "summary": "Fulton Breakefield Broenniman LLC significantly reduced its stake in Danaher Corporation by 27.9% in Q4, selling 18,647 shares and retaining 48,301 shares valued at $11.06 million. The article also notes Danaher's strong Q4 earnings, surpassing analyst estimates, and a recent dividend increase from $0.32 to $0.40 per share, yielding 0.8%. Analysts maintain a \"Moderate Buy\" rating for Danaher, with an average price target of $253.79.", "sentiment_score": 0.252561, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "The Osterweis Fund's Danaher Corp(DHR) Holding History", "url": "https://www.gurufocus.com/guru-portfolio/The%20Osterweis%20Fund/DHR", "date": "2026-04-07", "summary": "This article details The Osterweis Fund's historical holdings in Danaher Corp (DHR), including the number of shares, current market value, and percentage of portfolio. It also features a chart showing quarterly buys and sells, though currently indicating no recent activity, and lists recent news articles related to Danaher Corp.", "sentiment_score": 0.030395, "sentiment_label": "Neutral", "relevance_score": 0.346705, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Danaher: After a Long Reset Period, Profit Growth Looks Likely to Accelerate in the Medium Term", "url": "https://www.morningstar.com/company-reports/1464105-danaher-after-a-long-reset-period-profit-growth-looks-likely-to-accelerate-in-the-medium-term", "date": "2026-04-06", "summary": "Life science stocks, including Danaher's, have experienced pressure since late 2022. However, with expected high single-digit profit rebound in 2026 and potential further acceleration in 2027-30, there is growing positive momentum for the industry and Danaher's profit growth trajectory.", "sentiment_score": 0.443411, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.871, "confidence": 0.87 } }, { "source": "alpha_vantage", "title": "Verra Mobility (NASDAQ: VRRM) details 2026 proxy, pay plan and 2025 results", "url": "https://www.stocktitan.net/sec-filings/VRRM/def-14a-verra-mobility-corp-definitive-proxy-statement-b98ba2eedb4c.html", "date": "2026-04-06", "summary": "Verra Mobility (NASDAQ: VRRM) has released details for its 2026 annual meeting, including proposals for electing three Class II directors, advisory votes on executive compensation and its frequency, and the ratification of Deloitte & Touche LLP as its independent auditor. The company reported strong financial performance for fiscal year 2025, with revenues of $979.1 million and Adjusted EBITDA of $415.9 million. The proxy statement also details the compensation philosophy, which is heavily perfo", "sentiment_score": 0.12689, "sentiment_label": "Neutral", "relevance_score": 0.618538, "sentiment": { "label": "negative", "score": -0.103, "confidence": 0.1 } }, { "source": "alpha_vantage", "title": "Danaher (DHR) Analyst Rating: Evercore ISI Lowers Price Target", "url": "https://www.gurufocus.com/news/8776620/danaher-dhr-analyst-rating-evercore-isi-lowers-price-target-dhr-stock-news", "date": "2026-04-06", "summary": "Evercore ISI Group has maintained an \"Outperform\" rating for Danaher (DHR) but lowered its price target from $254.00 to $225.00, an 11.42% decrease. Despite this adjustment, the overall analyst consensus for Danaher remains positive. Danaher, specializing in scientific instruments and consumables, shows an average target price of $262.62 from 20 analysts and an \"Outperform\" recommendation from 26 brokerage firms.", "sentiment_score": 0.125968, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.128, "confidence": 0.13 } }, { "source": "alpha_vantage", "title": "Danaher (DHR) Analyst Rating: Evercore ISI Lowers Price Target", "url": "https://www.gurufocus.com/news/8776620/danaher-dhr-analyst-rating-evercore-isi-lowers-price-target-dhr-stock-news?mobile=true", "date": "2026-04-06", "summary": "Evercore ISI Group has maintained its \"Outperform\" rating for Danaher (DHR) but lowered its price target from $254.00 to $225.00, a decrease of 11.42%. Despite this adjustment, the overall analyst consensus for Danaher remains positive, with an average target price of $262.62 from 20 analysts, suggesting a significant upside from the current price. GuruFocus also estimates a fair value for DHR at $248.44.", "sentiment_score": -0.181363, "sentiment_label": "Somewhat-Bearish", "relevance_score": 0.987721, "sentiment": { "label": "negative", "score": -0.128, "confidence": 0.13 } }, { "source": "alpha_vantage", "title": "Danaher Corporation (DHR) Stock Forecasts", "url": "https://finance.yahoo.com/research/reports/MS_0P000001MV_AnalystReport_1775484729000", "date": "2026-04-06", "summary": "This page is a privacy consent form from Yahoo that discusses the use of cookies and personal data. It explains that Yahoo and its partners use cookies for site functionality, security, user authentication, and analytics. Users are given options to accept all cookies, reject all cookies, or manage their privacy settings.", "sentiment_score": 0.049396, "sentiment_label": "Neutral", "relevance_score": 0.912357, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Danaher’s Profit Report Challenge: Will First Quarter 2026 Address the Valuation Discrepancy Caused by Masimo?", "url": "https://www.bitget.com/amp/news/detail/12560605340616", "date": "2026-04-06", "summary": "Danaher (DHR) shares are facing a significant valuation discrepancy, with a high price-to-earnings ratio suggesting optimism despite a nearly 20% drop in 2026. This decline is largely attributed to investor skepticism following the acquisition of Masimo, which introduced new risks and challenged traditional views of Danaher's business model. The upcoming Q1 2026 earnings report on April 21st will be critical in determining if the company can demonstrate sufficient revenue growth to bridge the ga", "sentiment_score": -0.435479, "sentiment_label": "Bearish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.694, "confidence": 0.69 } }, { "source": "alpha_vantage", "title": "Electron Microscopes Market Is Going to Boom |• Thermo Fisher Scientific • JEOL Ltd.", "url": "https://www.openpr.com/news/4456694/electron-microscopes-market-is-going-to-boom-thermo-fisher", "date": "2026-04-06", "summary": "Worldwide Market Reports has released a comprehensive research study on the Electron Microscopes Market, forecasting its growth from 2026 to 2033. The report, developed using primary and secondary research, details market size, competitive landscape, key players like Thermo Fisher Scientific and JEOL Ltd., and segmentation by type and application. It also provides insights into regional trends, growth drivers, challenges, and opportunities for stakeholders.", "sentiment_score": 0.34039, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.618777, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Evercore ISI Adjusts Danaher Price Target to $225 From $254, Maintains Outperform Rating", "url": "https://www.marketscreener.com/news/evercore-isi-adjusts-danaher-price-target-to-225-from-254-maintains-outperform-rating-ce7e51d2d18df426", "date": "2026-04-06", "summary": "Evercore ISI has adjusted its price target for Danaher Corporation (DHR) to $225, down from $254, while reiterating an \"Outperform\" rating on the stock. Danaher is a diversified industrial and technology group focused on diagnostic, life sciences, and biotechnology equipment. The company's net sales are geographically distributed, with significant portions in the United States, China, and other international markets.", "sentiment_score": -0.232413, "sentiment_label": "Somewhat-Bearish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.2, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "Rathbones Group PLC Has $60.78 Million Stock Holdings in Danaher Corporation $DHR", "url": "https://www.marketbeat.com/instant-alerts/filing-rathbones-group-plc-has-6078-million-stock-holdings-in-danaher-corporation-dhr-2026-04-06/", "date": "2026-04-06", "summary": "Rathbones Group PLC reduced its stake in Danaher Corporation by 5.0% in the fourth quarter, selling 13,971 shares but still holding 265,499 shares valued at approximately $60.78 million. Danaher recently increased its quarterly dividend to $0.40 per share, resulting in an annualized dividend of $1.60 and a yield of 0.8%. The company also exceeded Wall Street's Q4 earnings and revenue estimates, reporting $2.23 EPS and $6.84 billion in revenue with a positive consensus price target of $253.55 fro", "sentiment_score": 0.435506, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Major Investors Accumulate Danaher Shares Amid Price Weakness", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/major-investors-accumulate-danaher-shares-amid-price-weakness/69085794", "date": "2026-04-06", "summary": "Major institutional investors are increasing their holdings in Danaher despite recent price weakness, seeing it as an opportune time to buy before its annual low. The company's upcoming Q1 earnings report on April 21, 2026, and its strategic $9.9 billion acquisition of Masimo, are key factors drawing investor attention and maintaining a \"Moderate Buy\" analyst consensus. This acquisition is expected to bolster Danaher's diagnostics segment and expand its technological portfolio.", "sentiment_score": 0.503469, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.153, "confidence": 0.15 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Microscopes: Precision in Scientific Imaging", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/thermo-fisher-microscopes-precision-in-scientific-imaging/69082878", "date": "2026-04-05", "summary": "This article details how Thermo Fisher microscopes are crucial for scientific imaging across various research and industrial applications. It highlights their advanced optical and electron models, cutting-edge features like high-resolution optics, fluorescence capabilities, and automation. The article also discusses their market relevance, competitive landscape, ongoing innovations, and significant impact on global health and scientific discovery.", "sentiment_score": 0.113982, "sentiment_label": "Neutral", "relevance_score": 0.60529, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Danaher's Strategic Ambitions: A Pivotal Period Ahead", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/danaher-s-strategic-ambitions-a-pivotal-period-ahead/69077492", "date": "2026-04-05", "summary": "Danaher Corporation is at a critical juncture, facing the integration of its $9.9 billion Masimo acquisition and an imminent quarterly earnings report. Despite competitive pressures and a 20% gap from its 52-week high, analysts see upside potential, with the stock potentially undervalued. The market will be closely watching how Danaher balances this major expansion with its consistent dividend payments and long-term growth strategy.", "sentiment_score": 0.256985, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Global Trust Asset Management LLC Grows Position in Danaher Corporation $DHR", "url": "https://www.marketbeat.com/instant-alerts/filing-global-trust-asset-management-llc-grows-position-in-danaher-corporation-dhr-2026-04-04/", "date": "2026-04-04", "summary": "Global Trust Asset Management LLC significantly increased its stake in Danaher Corporation by 719.8% in Q4, acquiring 5,694 additional shares and bringing its total holdings to 6,485 shares valued at approximately $1.485 million. Analysts maintain a \"Moderate Buy\" rating for Danaher, with a consensus price target of $253.55, following the company's Q4 earnings beat and a dividend increase. The company reported EPS of $2.23 and revenue of $6.84 billion, surpassing estimates.", "sentiment_score": 0.458978, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.7, "confidence": 0.7 } }, { "source": "alpha_vantage", "title": "DGX Stock News Today | Earnings, Events & Price Alerts", "url": "https://intellectia.ai/en/stock/DGX/news", "date": "2026-04-04", "summary": "This article provides recent news and event updates for Quest Diagnostics (DGX), including their upcoming Q1 2026 financial results announcement and the launch of an AI companion for lab data analysis. It also highlights leadership appointments, dividend increases, and stock performance milestones for the company.", "sentiment_score": 0.108759, "sentiment_label": "Neutral", "relevance_score": 0.642949, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Danaher Corporation (1DHR.MI) stock price, news, quote and history", "url": "https://sg.finance.yahoo.com/quote/1DHR.MI/earnings-calls/", "date": "2026-04-04", "summary": "This page provides comprehensive information on Danaher Corporation (1DHR.MI), including its stock price, news, quotes, and historical data. It offers an overview of the company's operations across Biotechnology, Life Sciences, and Diagnostics segments, along with key financial statistics, performance metrics, and comparison tools with similar companies.", "sentiment_score": 0.088595, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Danaher Corporation $DHR Shares Bought by Aberdeen Group plc", "url": "https://www.marketbeat.com/instant-alerts/filing-danaher-corporation-dhr-shares-bought-by-aberdeen-group-plc-2026-04-03/", "date": "2026-04-03", "summary": "Aberdeen Group plc increased its stake in Danaher Corporation (NYSE:DHR) by 12.0% in the fourth quarter, now owning 1.29 million shares valued at approximately $295.9 million. This transaction is part of a broader trend of institutional investors holding a significant portion, about 79.05%, of Danaher's stock. The company's recent strong financial performance, increased dividend, and positive analyst ratings contribute to a \"Moderate Buy\" consensus.", "sentiment_score": 0.54578, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "Danaher Corp. Experiences Valuation Adjustment Amid Competitive Market Landscape", "url": "https://www.marketsmojo.com/news/stocks-in-action/danaher-corporations-valuation-grade-downgraded-from-very-expensive-to-expensive-3930696", "date": "2026-04-02", "summary": "Danaher Corp., a significant player in the Pharmaceuticals & Biotechnology sector, has seen a valuation adjustment with its stock price at $190.79, reflecting a -4.79% return over the past year. The company's financial metrics include a P/E ratio of 41 and a dividend yield of 0.54%, indicating a competitive position but also challenges in growth compared to its peers like Abbott Laboratories and Thermo Fisher Scientific.", "sentiment_score": -0.244357, "sentiment_label": "Somewhat-Bearish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.178, "confidence": 0.18 } }, { "source": "alpha_vantage", "title": "AAV Genome Sequencing Service Market Is Booming Rapidly with Strong Demand By 2033 | Thermo Fisher Scientific, Illumina, Danaher Corporation", "url": "https://www.openpr.com/news/4452449/aav-genome-sequencing-service-market-is-booming-rapidly-with", "date": "2026-04-02", "summary": "Coherent Market Insights has published a new research study on the Global \"AAV Genome Sequencing Service Market\" forecasting growth through 2033. The report segments the market by type, application, end-user, and region, identifying key players like Thermo Fisher Scientific, Illumina, and Danaher Corporation. It aims to provide a comprehensive analysis of market trends, drivers, restraints, competitive landscape, and regional dynamics to aid strategic decision-making.", "sentiment_score": 0.73525, "sentiment_label": "Bullish", "relevance_score": 0.849765, "sentiment": { "label": "positive", "score": 0.421, "confidence": 0.42 } }, { "source": "alpha_vantage", "title": "Triad Investment Management Purchases New Stake in Danaher Corporation $DHR", "url": "https://www.marketbeat.com/instant-alerts/filing-triad-investment-management-purchases-new-stake-in-danaher-corporation-dhr-2026-04-02/", "date": "2026-04-02", "summary": "Triad Investment Management has acquired a new stake in Danaher Corporation, purchasing 21,540 shares valued at approximately $4.93 million, making it their sixth-largest position. Other institutional investors have also increased their holdings in Danaher, which recently exceeded quarterly earnings and revenue estimates and raised its quarterly dividend. The company maintains a \"Moderate Buy\" rating from analysts with an average target price of $253.55.", "sentiment_score": 0.473816, "sentiment_label": "Bullish", "relevance_score": 0.958836, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Bank Pictet & Cie Europe AG Boosts Stock Position in Danaher Corporation $DHR", "url": "https://www.marketbeat.com/instant-alerts/filing-bank-pictet-cie-europe-ag-boosts-stock-position-in-danaher-corporation-dhr-2026-04-02/", "date": "2026-04-02", "summary": "Bank Pictet & Cie Europe AG significantly increased its stake in Danaher Corporation by 25.4% during the fourth quarter, making DHR its 15th largest holding. Several other hedge funds also adjusted their positions in Danaher, which recently reported strong earnings, beating analyst estimates, and increased its quarterly dividend. The company's stock shows a \"Moderate Buy\" consensus rating from analysts with an average target price of $253.55.", "sentiment_score": 0.430297, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "alpha_vantage", "title": "Banque Pictet & Cie SA Purchases 79,407 Shares of Danaher Corporation $DHR", "url": "https://www.marketbeat.com/instant-alerts/filing-banque-pictet-cie-sa-purchases-79407-shares-of-danaher-corporation-dhr-2026-04-02/", "date": "2026-04-02", "summary": "Banque Pictet & Cie SA significantly increased its stake in Danaher Corporation (NYSE:DHR) during the fourth quarter, acquiring an additional 79,407 shares, bringing its total holdings to 140,037 shares valued at approximately $32.06 million. Danaher reported strong Q4 earnings, beating analyst expectations with $2.23 EPS and $6.84 billion in revenue, and has also increased its quarterly dividend to $0.40 per share. Analysts maintain a \"Moderate Buy\" rating for the stock, with an average target ", "sentiment_score": 0.491908, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--VYNE, MASI, IBCP, and HCBN", "url": "https://www.sahmcapital.com/news/content/shareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-vyne-masi-ibcp-and-hcbn-2026-04-01", "date": "2026-04-02", "summary": "Monteverde & Associates PC, a class action firm, is investigating several mergers impacting shareholders of VYNE Therapeutics Inc., Masimo Corporation, Independent Bank Corporation, and HCB Financial Corp. The firm is encouraging shareholders to seek more information regarding the terms of these transactions, including the proposed ownership percentages for VYNE shareholders and the cash/stock considerations for Masimo, IBCP, and HCBN shareholders. They emphasize their track record in recovering", "sentiment_score": 0.143069, "sentiment_label": "Neutral", "relevance_score": 0.614807, "sentiment": { "label": "positive", "score": 0.447, "confidence": 0.45 } }, { "source": "alpha_vantage", "title": "3 Reasons to Avoid DHR and 1 Stock to Buy Instead", "url": "https://www.barchart.com/story/news/1108858/3-reasons-to-avoid-dhr-and-1-stock-to-buy-instead", "date": "2026-04-02", "summary": "This article recommends avoiding Danaher (DHR) due to concerns about its organic revenue growth, shrinking adjusted operating margin, and dropping free cash flow margin. The analysis suggests Danaher's core business is faltering and that its declining profitability and cash flow raise questions. Instead, the authors recommend other market-beating stocks, highlighting past recommendations like Nvidia and Kadant.", "sentiment_score": -0.404278, "sentiment_label": "Bearish", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "Quantum-Si (NASDAQ: QSI) plans 2026 virtual meeting and pay vote", "url": "https://www.stocktitan.net/sec-filings/QSI/def-14a-quantum-si-inc-definitive-proxy-statement-d8c8792f6cd4.html", "date": "2026-04-01", "summary": "Quantum-Si (NASDAQ: QSI) will hold its fully virtual 2026 annual shareholder meeting on May 15, 2026, at 1:00 p.m. Eastern, where stockholders will vote on electing ten directors, ratifying PricewaterhouseCoopers LLP as auditor, and approving a non-binding advisory say-on-pay for named executive officers. Founder Jonathan M. Rothberg, Ph.D., who beneficially owns all Class B shares, holds approximately 69.33% of the total voting power, effectively controlling the outcome of all proposals. The pr", "sentiment_score": 0.047713, "sentiment_label": "Neutral", "relevance_score": 0.643178, "sentiment": { "label": "negative", "score": -0.103, "confidence": 0.1 } }, { "source": "alpha_vantage", "title": "Worldwide Factors Influencing the Rapid Evolution of the Life Science Tools Market", "url": "https://www.openpr.com/news/4451119/worldwide-factors-influencing-the-rapid-evolution-of-the-life", "date": "2026-04-01", "summary": "The life science tools market is projected to reach $379.95 billion by 2030, growing at a CAGR of 13.5%. This growth is fueled by automation, increased investments in genomics and proteomics, demand for personalized medicine, and advancements in clinical diagnostics and drug discovery. Key players like F. Hoffmann-La Roche Ltd. and Thermo Fisher Scientific Inc. are driving innovation, exemplified by strategic acquisitions and the development of advanced sequencing platforms such as Illumina's Mi", "sentiment_score": 0.30464, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.729425, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Key Factors and Emerging Trends Shaping the Lab Supplies Market Landscape", "url": "https://www.openpr.com/news/4451078/key-factors-and-emerging-trends-shaping-the-lab-supplies-market", "date": "2026-04-01", "summary": "The lab supplies market is set to reach $60.9 billion by 2030, growing at an 8.5% CAGR, driven by advancements in life sciences, diagnostics, and automation. Key trends include increased demand for premium consumables, automated equipment, and a focus on safety and sustainability. Leading companies like Thermo Fisher Scientific and Danaher Corporation are innovating to enhance accuracy and efficiency, with acquisitions like Calibre Scientific's purchase of Dynalab Corp. expanding market reach an", "sentiment_score": 0.331427, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.822133, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Bikerumor.com", "title": "All New Liv Embolden Gets All the Right Updates for an Affordable Modern Trail", "description": "Liv's Embolden trail bike was a great option for ladies looking to get into the sport; however, the geo was a bit outdated...well, not anymore\nThe post All New Liv Embolden Gets All the Right Updates for an Affordable Modern Trail appeared first on Bikerumor.", "url": "https://bikerumor.com/liv-makes-necessary-updates-to-the-embolden-for-a-more-modern-trail-bike-at-a-good-price/", "date": "2026-04-08", "published_at": "2026-04-08T16:00:00Z", "sentiment": { "label": "positive", "score": 0.625, "confidence": 0.62 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Flow Cytometry Market Set to Surpass USD 12.19 Billion by 2035, Driven by Rising Demand for Precision Diagnostics – SNS Insider", "description": "Austin, United States, April 08, 2026 (GLOBE NEWSWIRE) -- SNS Insider reported that global Flow Cytometry Market was valued at USD 5.75 billion in 2025 and is expected to reach USD 12.19 billion by 2035, growing at a CAGR of 7.8% over the forecast period of 2…", "url": "https://www.globenewswire.com/news-release/2026/04/08/3270347/0/en/Flow-Cytometry-Market-Set-to-Surpass-USD-12-19-Billion-by-2035-Driven-by-Rising-Demand-for-Precision-Diagnostics-SNS-Insider.html", "date": "2026-04-08", "published_at": "2026-04-08T15:33:00Z", "sentiment": { "label": "positive", "score": 0.718, "confidence": 0.72 } }, { "source": "news", "source_name": "Yahoo Entertainment", "title": "Evercore ISI Cuts Danaher (DHR) Price Target, Adds Shares to Tactical Outperform List", "description": "", "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_c083ef15-d8fa-49c0-8b46-02592de8029a", "date": "2026-04-08", "published_at": "2026-04-08T04:14:38Z", "sentiment": { "label": "positive", "score": 0.2, "confidence": 0.2 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Purvalanol A (CDK Inhibitor) Market Report 2026: Expanding Molecular Biology and Cancer Research Fuelling Market Growth", "description": "Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The \"Purvalanol A (CDK Inhibitor) Market Report 2026\" has been added to ResearchAndMarkets.com's offering. ...", "url": "https://www.globenewswire.com/news-release/2026/04/07/3269499/28124/en/Purvalanol-A-CDK-Inhibitor-Market-Report-2026-Expanding-Molecular-Biology-and-Cancer-Research-Fuelling-Market-Growth.html", "date": "2026-04-07", "published_at": "2026-04-07T16:13:00Z", "sentiment": { "label": "negative", "score": -0.527, "confidence": 0.53 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Global Biopreservation Market Analysis by Product Type, Application, End User, and Region, 2025-2035: Cell and Gene Therapies Drive Biopreservation Demand", "description": "Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The \"Biopreservation Market - A Global and Regional Analysis: Product Type, Application, End User, and Regional Analysis - Analysis and Forecast, 2025-2035\" has been added to ResearchAndMarkets.com's offering.", "url": "https://www.globenewswire.com/news-release/2026/04/07/3269491/28124/en/Global-Biopreservation-Market-Analysis-by-Product-Type-Application-End-User-and-Region-2025-2035-Cell-and-Gene-Therapies-Drive-Biopreservation-Demand.html", "date": "2026-04-07", "published_at": "2026-04-07T16:04:00Z", "sentiment": { "label": "negative", "score": -0.128, "confidence": 0.13 } }, { "source": "news", "source_name": "The Irish Times", "title": "Fisheries agency spent about €60,000 on communications training prior to PAC appearance", "description": "Payment represented ‘extraordinary unjustifiable use of public money’", "url": "https://www.irishtimes.com/politics/2026/04/07/fisheries-agency-spent-about-60000-on-communications-training-prior-to-pac-appearance/", "date": "2026-04-07", "published_at": "2026-04-07T05:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Membrane Filters Market Size to Surpass USD 30.21 Billion by 2035 | SNS Insider", "description": "The Membrane Filters Market is expanding as demand grows across water treatment and life sciences, with the U.S. segment increasing from USD 4.61 billion in 2025 to USD 11.03 billion by 2035 amid regulatory and industrial growth. The Membrane Filters Market i…", "url": "https://www.globenewswire.com/news-release/2026/04/06/3268318/0/en/Membrane-Filters-Market-Size-to-Surpass-USD-30-21-Billion-by-2035-SNS-Insider.html", "date": "2026-04-06", "published_at": "2026-04-06T10:30:00Z", "sentiment": { "label": "positive", "score": 0.273, "confidence": 0.27 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Molecular Diagnostics Market Size is Expected to Reach USD 43.50 Billion by 2035 Owing to the Surging Demand for Accurate and Early Disease Detection Globally | SNS Insider", "description": "Molecular diagnostics market to grow from $18.26 Bn to $43.50 Bn by 2035, driven by PCR, NGS, and demand for early, precise diagnosis....", "url": "https://www.globenewswire.com/news-release/2026/04/03/3267957/0/en/Molecular-Diagnostics-Market-Size-is-Expected-to-Reach-USD-43-50-Billion-by-2035-Owing-to-the-Surging-Demand-for-Accurate-and-Early-Disease-Detection-Globally-SNS-Insider.html", "date": "2026-04-03", "published_at": "2026-04-03T09:00:00Z", "sentiment": { "label": "negative", "score": -0.226, "confidence": 0.23 } }, { "source": "news", "source_name": "Inside Higher Ed", "title": "What May (or May Not) Get University Employees Fired", "description": "What May (or May Not) Get University Employees Fired\n\nkjohnsonbowles…\n\nFri, 04/03/2026 - 03:00 AM\n\nStories of performance and behavioral issues abound in higher education. From a list of scenarios, could you guess how many ended with someone being fired?\n \n B…", "url": "https://www.insidehighered.com/opinion/columns/just-explain-it-me/2026/04/03/why-accountability-inconsistently-enforced", "date": "2026-04-03", "published_at": "2026-04-03T07:00:00Z", "sentiment": { "label": "negative", "score": -0.896, "confidence": 0.9 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "[Latest] Global Environmental Mass Spectrometry Market Size/Share Worth USD 6.47 Billion by 2035 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)", "description": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Environmental Mass Spectrometry Market size & share revenue was valued at approximately USD 2.84 Billion in 2025 and is expected…", "url": "https://www.globenewswire.com/news-release/2026/04/02/3267246/0/en/Latest-Global-Environmental-Mass-Spectrometry-Market-Size-Share-Worth-USD-6-47-Billion-by-2035-at-a-7-6-CAGR-Custom-Market-Insights-Analysis-Outlook-Leaders-Report-Trends-Forecast-.html", "date": "2026-04-02", "published_at": "2026-04-02T11:30:00Z", "sentiment": { "label": "positive", "score": 0.859, "confidence": 0.86 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Antimicrobial Resistance Surveillance Market Set to Reach USD 11.17 Billion by 2035 – SNS Insider", "description": "Rising prevalence of drug-resistant infections and government-led monitoring initiatives drive a steady 5.47% CAGR through 2035. Rising prevalence of drug-resistant infections and government-led monitoring initiatives drive a steady 5.47% CAGR through 2035.", "url": "https://www.globenewswire.com/news-release/2026/04/02/3267148/0/en/Antimicrobial-Resistance-Surveillance-Market-Set-to-Reach-USD-11-17-Billion-by-2035-SNS-Insider.html", "date": "2026-04-02", "published_at": "2026-04-02T08:30:00Z", "sentiment": { "label": "neutral", "score": 0.026, "confidence": 0.03 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Wilms Tumor Protein Market Outlook 2026-2030 and 2035 Shows 6.9% CAGR as Rising Investment in Oncology Research Accelerates Industry Growth", "description": "Dublin, March 31, 2026 (GLOBE NEWSWIRE) -- The \"Wilms Tumor Protein Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The report provides a comprehensive analysis, covering market statistics, regional shares, competitor data, market seg…", "url": "https://www.globenewswire.com/news-release/2026/03/31/3265766/28124/en/Wilms-Tumor-Protein-Market-Outlook-2026-2030-and-2035-Shows-6-9-CAGR-as-Rising-Investment-in-Oncology-Research-Accelerates-Industry-Growth.html", "date": "2026-03-31", "published_at": "2026-03-31T15:07:00Z", "sentiment": { "label": "positive", "score": 0.153, "confidence": 0.15 } }, { "source": "news", "source_name": "Bikerumor.com", "title": "Mondraker Leaves Something to the Imagination with Early Tease of Avinox-Powered ZENDIT eMTB", "description": "In a cheeky move by Mondraker, they’ve revealed almost everything about their new ZENDIT eMTB, except for the motor specs.\nThe post Mondraker Leaves Something to the Imagination with Early Tease of Avinox-Powered ZENDIT eMTB appeared first on Bikerumor.", "url": "https://bikerumor.com/mondraker-leaves-something-to-the-imagination-with-early-tease-of-avinox-powered-zendit-emtb/", "date": "2026-03-27", "published_at": "2026-03-27T19:52:32Z", "sentiment": { "label": "negative", "score": -0.557, "confidence": 0.56 } }, { "source": "news", "source_name": "Yahoo Entertainment", "title": "Danaher (DHR) Projects 2026 Revenue Growth at TD Cowen 46th Annual Health Care Conference", "description": "", "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_1f8a8b1e-8c4c-490c-a5cd-c476afe69798", "date": "2026-03-24", "published_at": "2026-03-24T14:43:04Z", "sentiment": { "label": "positive", "score": 0.9, "confidence": 0.9 } }, { "source": "news", "source_name": "Yahoo Entertainment", "title": "Is Danaher Corporation (DHR) A Good Stock To Buy Now?", "description": "", "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_b832ae15-1caa-4fd5-94ba-78f547897ce6", "date": "2026-03-20", "published_at": "2026-03-20T20:03:35Z", "sentiment": { "label": "positive", "score": 0.44, "confidence": 0.44 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Biopsy Devices Market Size Projected to Reach USD 5.08 Billion by 2035; Increasing Incidence of Cancer to Drive Market Growth Globally – SNS Insider", "description": "Rising Demand for Minimally Invasive, Image-Guided Procedures and Expanding Healthcare Infrastructure Accelerate Global Market Expansion. Rising Demand for Minimally Invasive, Image-Guided Procedures and Expanding Healthcare Infrastructure Accelerate Global M…", "url": "https://www.globenewswire.com/news-release/2026/03/20/3259711/0/en/Biopsy-Devices-Market-Size-Projected-to-Reach-USD-5-08-Billion-by-2035-Increasing-Incidence-of-Cancer-to-Drive-Market-Growth-Globally-SNS-Insider.html", "date": "2026-03-20", "published_at": "2026-03-20T12:14:00Z", "sentiment": { "label": "negative", "score": -0.572, "confidence": 0.57 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Genomics Market to Reach USD 85.09 Billion by 2030 | MarketsandMarkets™", "description": "Advancements in NGS, AI-driven bioinformatics, and expanding precision medicine initiatives are positioning genomics as a strategic pillar in modern healthcare, diagnostics, and drug discovery. Advancements in NGS, AI-driven bioinformatics, and expanding prec…", "url": "https://www.globenewswire.com/news-release/2026/03/19/3259211/0/en/Genomics-Market-to-Reach-USD-85-09-Billion-by-2030-MarketsandMarkets.html", "date": "2026-03-19", "published_at": "2026-03-19T14:30:00Z", "sentiment": { "label": "neutral", "score": 0.026, "confidence": 0.03 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—MASI, AVO, CVGW, and TPH", "description": "NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC\r\n (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securitie…", "url": "https://www.globenewswire.com/news-release/2026/03/19/3259206/0/en/URGENT-The-M-A-Class-Action-Firm-Launches-Legal-Inquiry-for-the-Merger-MASI-AVO-CVGW-and-TPH.html", "date": "2026-03-19", "published_at": "2026-03-19T14:28:00Z", "sentiment": { "label": "positive", "score": 0.59, "confidence": 0.59 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Dental Fillers Market Report 2026-2032: Emerging Opportunities, Market Dynamics, Competitive Landscape Analysis", "description": "Dublin, March 18, 2026 (GLOBE NEWSWIRE) -- The \"Dental Fillers Market - Global Forecast 2026-2032\" report has been added to ResearchAndMarkets.com's offering.", "url": "https://www.globenewswire.com/news-release/2026/03/18/3257951/28124/en/Dental-Fillers-Market-Report-2026-2032-Emerging-Opportunities-Market-Dynamics-Competitive-Landscape-Analysis.html", "date": "2026-03-18", "published_at": "2026-03-18T09:07:00Z", "sentiment": { "label": "positive", "score": 0.66, "confidence": 0.66 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "NOV Appoints Sanjay Chowbey, President & CEO of Kennametal Inc., to the Board of Directors", "description": "NOV Announces Appointment of Sanjay Chowbey...", "url": "https://www.globenewswire.com/news-release/2026/03/17/3257776/0/en/NOV-Appoints-Sanjay-Chowbey-President-CEO-of-Kennametal-Inc-to-the-Board-of-Directors.html", "date": "2026-03-17", "published_at": "2026-03-17T22:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Predictive Biomarkers Market to Reach USD 156.85 Billion by 2035; Rising Adoption of Precision Medicine and Targeted Therapies Driving Market Growth – SNS Insider", "description": "Rising Chronic Disease Burden, AI-Driven Biomarker Discovery, and Expanding Companion Diagnostics Pipelines Fuel Unprecedented Market Expansion. Rising Chronic Disease Burden, AI-Driven Biomarker Discovery, and Expanding Companion Diagnostics Pipelines Fuel U…", "url": "https://www.globenewswire.com/news-release/2026/03/17/3257053/0/en/Predictive-Biomarkers-Market-to-Reach-USD-156-85-Billion-by-2035-Rising-Adoption-of-Precision-Medicine-and-Targeted-Therapies-Driving-Market-Growth-SNS-Insider.html", "date": "2026-03-17", "published_at": "2026-03-17T11:45:00Z", "sentiment": { "label": "negative", "score": -0.477, "confidence": 0.48 } }, { "source": "news", "source_name": "Electrek", "title": "Aventon launches high-end full-suspension electric mountain bike at half the cost of the big names", "description": "Aventon has just unveiled its latest electric mountain bike, the new Current, bringing a full-suspension eMTB platform to the company’s lineup that blends trail-ready performance with the connected tech features Aventon has been steadily building into its bik…", "url": "http://electrek.co/2026/03/16/aventon-launches-high-end-full-suspension-electric-mountain-bike-at-half-the-cost-of-the-big-names/", "date": "2026-03-16", "published_at": "2026-03-16T17:33:55Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "BroBible", "title": "Wayne Tinkle Shows Class During Messy Ouster As Oregon State Disrespects Fired Basketball Coach", "description": "Wayne Tinkle will not return to coach college basketball at Oregon State next season. The 20-year head coaching veteran does not pan to retire but the Beavers showed him the door. He was replaced by Michigan assistant Justin Joyner after 12 years at the helm.…", "url": "https://brobible.com/sports/article/wayne-tinkle-oregon-state-basketball-disrespect-scott-barnes-social-media-snub-ad/", "date": "2026-03-16", "published_at": "2026-03-16T13:51:01Z", "sentiment": { "label": "negative", "score": -0.468, "confidence": 0.47 } }, { "source": "news", "source_name": "Fox News", "title": "California State University board meeting falls into chaos amid SJSU lawsuit vs Trump admin over trans scandal", "description": "CSU and San Jose State University sued the federal government over Title IX transgender volleyball findings after Education Secretary threatened funding cuts.", "url": "https://www.foxnews.com/sports/california-state-university-board-meeting-falls-chaos-amid-sjsu-lawsuit-vs-trump-admin-over-trans-scandal", "date": "2026-03-12", "published_at": "2026-03-12T01:51:19Z", "sentiment": { "label": "negative", "score": -1.0, "confidence": 1.0 } }, { "source": "pubmed", "pmid": "41951782", "title": "Reproductive hormone stability with prolonged intranasal oxytocin in adults with obesity.", "authors": "Galbiati F et al.", "journal": "International journal of obesity (2005)", "date": "2026 Apr 9", "url": "https://pubmed.ncbi.nlm.nih.gov/41951782/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41944812", "title": "Toward actionable interventions in human aging (12th ARDD meeting, 2025).", "authors": "Dekan A et al.", "journal": "Aging", "date": "2026 Apr 6", "url": "https://pubmed.ncbi.nlm.nih.gov/41944812/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41933068", "title": "Longer duration of amenorrhea is associated with lower delay discounting and less hedonic eating in girls and young women with low-weight eating disorders.", "authors": "Wronski ML et al.", "journal": "Scientific reports", "date": "2026 Apr 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41933068/", "sentiment": { "label": "negative", "score": -0.542, "confidence": 0.54 } }, { "source": "pubmed", "pmid": "41826557", "title": "Adaptable, quantitative CRISPR/Cas12a-based assay for cytomegalovirus DNA in infant saliva.", "authors": "Chao K et al.", "journal": "Scientific reports", "date": "2026 Mar 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41826557/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } } ] } }